- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Delhivery has announced a board meeting to approve the appointment of Ms. Namita Thapar as an Independent Director for five years, effective from February 17, 2025, pending member approval. Ms. Thapar is currently the Executive Director at Emcure Pharmaceuticals, overseeing a significant revenue stream of approximately ₹8,000 crores. Her extensive background in finance and her recognition in various corporate accolades highlight her expertise. This strategic addition to the board could positively impact governance and enhance investor sentiment, offering new opportunities for growth and operational insight.